Clinical Trial: Study of Testosterone and rHGH in FSHD

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: Study of Testosterone and rHGH in FSHD (STARFISH): A Proof-of-Concept Study

Brief Summary: The purpose of this study is to investigate the safety and tolerability of combination therapy with recombinant human growth hormone (rHGH) and testosterone in adult male patients with facioscapulohumeral muscular dystrophy (FSHD) over 24 weeks.